Four insights:
1. Baricaid is intended for patients with pain and pinched nerves affiliated with disc herniation in the lumbar spine where traditional treatment has not worked. The patients typically have annular defects that are at risk of recurring herniation.
2. The device features an occlusion component consisting of woven polyester and a titanium bone anchor, connecting it to the vertebral body.
3. Baricaid was developed to prevent the recurrence of disc herniation by stopping defects in the annulus fibrosis.
4. A multicenter randomized trial revealed about a 50 percent decrease in the recurrence of symptomatic herniation during discectomy with Baricaid compared to traditional discectomy.
More articles on surface technology:
10 key updates in surface technology
OPM releases positive findings in 3D-printed PEKK study
PrinterPrezz receives certification to 3D print medical devices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
